Albany Molecular Research, Inc. (NASDAQ:AMRI)
CAPS Rating:
The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.
RSS Headlines
Fool UK
Recs
Growing by pharmaceutical development and licensing or partnership with large pharma corps.